Predictions
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.30
23.01.22
23.01.22
-
23.01.23
23.01.23
15.82%
06.02.22
06.02.22
Risky Investment
Canopy Growth Corp
Start price
Target price
Perf. (%)
€6.43
23.01.22
23.01.22
-
23.01.23
23.01.23
7.21%
06.02.22
06.02.22
Could be very worthwhile Investment >20% year
Epizyme Inc.
Start price
Target price
Perf. (%)
€1.10
27.01.22
27.01.22
€1.00
27.01.23
27.01.23
41.00%
05.02.22
05.02.22
Could be worthwhile Investment >10% per year
Capable Management
Bad culture
Innate Pharma
Start price
Target price
Perf. (%)
€4.12
10.01.22
10.01.22
-
10.01.23
10.01.23
-14.85%
01.02.22
01.02.22
Could be worthwhile Investment >10% per year
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€6.41
20.12.21
20.12.21
€7.20
20.12.22
20.12.22
-15.91%
30.01.22
30.01.22
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Novavax Inc.
Start price
Target price
Perf. (%)
€125.18
28.05.21
28.05.21
€200.00
28.05.22
28.05.22
-35.69%
29.01.22
29.01.22
Top 10 in its market
Very Future proof/growth oriented business model
Leading role in innovation
Significant cyclical dependencies
Supernus Pharmaceuticals
Start price
Target price
Perf. (%)
€25.20
25.01.21
25.01.21
€28.00
25.01.22
25.01.22
3.97%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€23.62
15.10.21
15.10.21
-
18.01.25
18.01.25
-45.89%
24.01.22
24.01.22
Could be worthwhile Investment >10% per year
Very high cyclical dependencies
Eledon Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€13.36
23.01.21
23.01.21
€100.00
23.01.22
23.01.22
-77.10%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Advaxis Inc.
Start price
Target price
Perf. (%)
€0.62
23.01.21
23.01.21
€60.00
23.01.22
23.01.22
-81.94%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Teligent Inc.
Start price
Target price
Perf. (%)
€0.99
23.01.21
23.01.21
-
23.01.22
23.01.22
-97.97%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Zosano Pharma Corp.
Start price
Target price
Perf. (%)
€31.33
23.01.21
23.01.21
-
23.01.22
23.01.22
-55.15%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.86
23.01.21
23.01.21
€3.00
23.01.22
23.01.22
-38.46%
24.01.22
24.01.22
Could be very worthwhile Investment >20% year
Higher risks for its business
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.02
09.01.22
09.01.22
-
09.01.23
09.01.23
-18.54%
23.01.22
23.01.22
Could be very worthwhile Investment >20% year
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.69
13.01.22
13.01.22
-
13.01.23
13.01.23
-12.15%
23.01.22
23.01.22
Could be very worthwhile Investment >20% year
Riot Blockchain Inc.
Start price
Target price
Perf. (%)
€17.60
10.01.22
10.01.22
-
10.01.23
10.01.23
-27.39%
23.01.22
23.01.22
Risky Investment
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€3.71
09.01.22
09.01.22
-
09.01.23
09.01.23
-11.02%
22.01.22
22.01.22
Could be worthwhile Investment >10% per year